Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults)

PURPOSE: To evaluate safety and effectiveness of biosimilar recombinant human growth hormone (rhGH; Omnitrope®) in adults with growth hormone deficiency (GHD), using data from the PATRO Adults study. METHODS: PATRO Adults was a post-marketing surveillance study conducted in hospitals and specialized...

Descripción completa

Detalles Bibliográficos
Autores principales: Höybye, Charlotte, Beck-Peccoz, Paolo, Murray, Robert D., Simsek, Suat, Stalla, Günter, Strasburger, Christian J., Urosevic, Dragan, Zouater, Hichem, Johannsson, Gudmundur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270854/
https://www.ncbi.nlm.nih.gov/pubmed/33742320
http://dx.doi.org/10.1007/s11102-021-01139-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270854/
https://www.ncbi.nlm.nih.gov/pubmed/33742320
http://dx.doi.org/10.1007/s11102-021-01139-2

Ejemplares similares